Reports for TEVA CANADA LIMITED
Company Name TEVA CANADA LIMITED |
||
|---|---|---|
Totals |
||
Shortage reports |
2928 |
|
| Actual shortage: | 212 (7%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 10 (0%) | |
| Resolved: | 2706 (92%) | |
Discontinuation Reports |
299 |
|
| To be discontinued: | 2 (1%) | |
| Discontinued: | 297 (99%) | |
| Reversed: | 0 (0%) | |
Late reports |
361 (11%) |
|
Overdue reports |
93 (43%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ACT AMLODIPINE | 10MG | TABLET | Resolved | 2020-11-06 | 2021-01-21 | 128034 |
| ACT AMLODIPINE | 5MG | TABLET | Resolved | 2023-02-09 | 2023-04-28 | 184204 |
| ACT AMLODIPINE | 2.5MG | TABLET | Resolved | 2017-03-17 | 2017-09-19 | 3348 |
| ACT AMLODIPINE | 10MG | TABLET | Resolved | 2021-09-30 | 2021-10-07 | 146443 |
| ACT AMLODIPINE | 5MG | TABLET | Resolved | 2020-11-06 | 2021-01-07 | 127998 |
| ACT AMLODIPINE | 5MG | TABLET | Resolved | 2022-12-15 | 2023-02-16 | 178518 |
| ACT AMPHETAMINE XR | 7.5MG 7.5MG 7.5MG 7.5MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2018-09-12 | 2018-12-29 | 61333 |
| ACT AMPHETAMINE XR | 25MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2021-03-25 | 2021-05-20 | 136286 |
| ACT AMPHETAMINE XR | 2.5MG 2.5MG 2.5MG 2.5MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2018-11-30 | 2019-01-31 | 68265 |
| ACT AMPHETAMINE XR | 5MG 5MG 5MG 5MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2018-09-06 | 2019-01-31 | 60075 |
| ACT AMPHETAMINE XR | 3.75MG 3.75MG 3.75MG 3.75MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2018-09-06 | 2019-01-31 | 60068 |
| ACT AMPHETAMINE XR | 20MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2021-09-23 | 2021-10-14 | 146092 |
| ACT AMPHETAMINE XR | 5MG | CAPSULE (EXTENDED RELEASE) | Avoided shortage | 2021-05-20 | 2021-07-08 | 139722 |
| ACT AMPHETAMINE XR | 30MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2021-07-15 | 2021-09-09 | 142610 |
| ACT AMPHETAMINE XR | 10MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2021-01-15 | 2021-03-11 | 131676 |
| ACT AMPHETAMINE XR | 6.25MG 6.25MG 6.25MG 6.25MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2018-09-12 | 2018-12-29 | 61330 |
| ACT AMPHETAMINE XR | 1.25MG 1.25MG 1.25MG 1.25MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2018-09-12 | 2018-12-29 | 61336 |
| ACT AMPHETAMINE XR | 15MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2021-01-15 | 2021-05-06 | 131679 |
| ACT ANASTROZOLE | 1MG | TABLET | Resolved | 2020-01-24 | 2021-01-28 | 104374 |
| ACT BORTEZOMIB | 3.5MG | POWDER FOR SOLUTION | Actual shortage | 2025-01-23 | 2025-01-23 | 248442 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-LAMOTRIGINE | 25MG | TABLET | Discontinued | 2019-04-11 | 2019-04-11 | 81388 |
| TEVA-LANSOPRAZOLE | 15MG | CAPSULE (DELAYED RELEASE) | Discontinued | 2025-04-29 | 2025-04-29 | 256085 |
| TEVA-LANSOPRAZOLE | 30MG | CAPSULE (DELAYED RELEASE) | Discontinued | 2025-04-25 | 2025-04-25 | 255824 |
| TEVA-LATANOPROST | 50MCG | SOLUTION | Discontinued | 2020-07-10 | 2020-07-10 | 120009 |
| TEVA-LISINOPRIL (TYPE P) | 20MG | TABLET | Discontinued | 2018-10-12 | 2018-10-12 | 63978 |
| TEVA-LISINOPRIL (TYPE P) | 5MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64909 |
| TEVA-LISINOPRIL (TYPE P) | 5MG | TABLET | Discontinued | 2019-04-11 | 2019-04-11 | 81298 |
| TEVA-LISINOPRIL (TYPE P) | 10MG | TABLET | Discontinued | 2019-04-11 | 2019-04-11 | 81400 |
| TEVA-LISINOPRIL (TYPE P) | 20MG | TABLET | Discontinued | 2020-01-24 | 2020-01-24 | 104257 |
| TEVA-LISINOPRIL (TYPE Z) | 10MG | TABLET | Discontinued | 2019-08-15 | 2019-08-15 | 91648 |
| TEVA-LISINOPRIL/HCTZ (TYPE P) | 12.5MG 10MG | TABLET | Discontinued | 2018-10-12 | 2018-10-12 | 63975 |
| TEVA-LISINOPRIL/HCTZ (TYPE P) | 12.5MG 20MG | TABLET | Discontinued | 2019-04-11 | 2019-04-11 | 81301 |
| TEVA-LISINOPRIL/HCTZ (TYPE P) | 25MG 20MG | TABLET | Discontinued | 2019-04-11 | 2019-04-11 | 81368 |
| TEVA-LOSARTAN/HCTZ | 50.0MG 12.5MG | TABLET | Discontinued | 2021-02-12 | 2021-02-12 | 133902 |
| TEVA-LOSARTAN/HCTZ | 100MG 25MG | TABLET | Discontinued | 2021-02-12 | 2021-02-12 | 133899 |
| TEVA-LOSARTAN/HCTZ | 100MG 12.5MG | TABLET | Discontinued | 2021-02-12 | 2021-02-12 | 133896 |
| TEVA-MEDROXYPROGESTERONE | 10MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256119 |
| TEVA-MEDROXYPROGESTERONE | 2.5MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256113 |
| TEVA-MEDROXYPROGESTERONE | 5MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256116 |
| TEVA-METOPROLOL | 50MG | TABLET | Discontinued | 2020-07-10 | 2020-07-10 | 119976 |